|
| |
Company Name: | Claritas Pharmaceuticals, Inc. |
Industry: | Research And Development In The Life Sciences |
Symbols/ Instruments: |
CLAS.H | -Claritas Pharmaceuticals, Inc. |
|
Date of Listing: | 19 May 2005 |
Fiscal Year-end: | DEC 31 |
Trading Status: | SUSPENDED |
Address: | 500 S. Sepulveda Blvd., Suite 212 Manhattan Beach,
90266 USA
|
Phone: | 1(888) 861-2008 |
Fax: | 1(403) 973-0624 |
Email Address: | bfarrell@kalytera.co |
Senior Executive: | Robert Farrell, President |
Listed companies wishing to update their information should click here.
|
|
|
| Info TSX Venture is a comprehensive database of information on NEX listed companies, including: |
|
|
|
|
| |